Free Trial

Calumet (NASDAQ:CLMT) Shares Pass Above Two Hundred Day Moving Average - What's Next?

Calumet logo with Energy background

Shares of Calumet, Inc. (NASDAQ:CLMT - Get Free Report) passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $15.02 and traded as high as $18.77. Calumet shares last traded at $18.67, with a volume of 404,574 shares changing hands.

Analyst Ratings Changes

CLMT has been the topic of several recent research reports. Zacks Research downgraded Calumet from a "hold" rating to a "strong sell" rating in a report on Tuesday, October 7th. Weiss Ratings reissued a "sell (e+)" rating on shares of Calumet in a report on Wednesday, October 8th. Finally, UBS Group raised their price objective on Calumet from $12.00 to $13.25 and gave the company a "neutral" rating in a report on Tuesday, August 12th. Four equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and two have given a Sell rating to the company. According to MarketBeat, Calumet presently has an average rating of "Hold" and a consensus target price of $18.71.

Get Our Latest Research Report on Calumet

Calumet Stock Performance

The stock has a market capitalization of $1.62 billion, a price-to-earnings ratio of -3.58 and a beta of 0.98. The company has a fifty day simple moving average of $17.31 and a 200 day simple moving average of $15.02.

Calumet (NASDAQ:CLMT - Get Free Report) last announced its quarterly earnings data on Friday, August 8th. The oil and gas company reported ($1.70) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.44) by ($1.26). The firm had revenue of $1.03 billion during the quarter, compared to the consensus estimate of $982.88 million. Calumet's revenue for the quarter was down 9.4% compared to the same quarter last year. During the same quarter last year, the company earned ($0.48) earnings per share. As a group, equities analysts predict that Calumet, Inc. will post -3.02 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. O Keefe Stevens Advisory Inc. lifted its stake in shares of Calumet by 2.2% in the 3rd quarter. O Keefe Stevens Advisory Inc. now owns 27,416 shares of the oil and gas company's stock valued at $500,000 after purchasing an additional 599 shares during the period. Corient Private Wealth LLC acquired a new position in shares of Calumet in the 2nd quarter valued at about $577,000. Squarepoint Ops LLC acquired a new position in Calumet during the 2nd quarter worth approximately $500,000. Engineers Gate Manager LP acquired a new position in Calumet during the 2nd quarter worth approximately $230,000. Finally, BNP Paribas Financial Markets raised its stake in Calumet by 18,512.3% during the 2nd quarter. BNP Paribas Financial Markets now owns 183,890 shares of the oil and gas company's stock worth $2,897,000 after buying an additional 182,902 shares during the period. 34.41% of the stock is owned by institutional investors and hedge funds.

Calumet Company Profile

(Get Free Report)

Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Calumet Right Now?

Before you consider Calumet, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calumet wasn't on the list.

While Calumet currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.